Professor Yugeesh Lankadeva
PhD, MBA, GAICD, BBMed (Hons)

Group Head

Location
Parkville Campus
30 Royal Parade
Parkville Victoria 3052

Research group
Translational Cardiovascular and Renal Research Group

Associate Professor Yugeesh Lankadeva

Biography

Professor Yugeesh Lankadeva is a National Health and Medical Research Council Emerging Leader Fellow. He leads the Stroke and Critical Care Priority Research Area and the Translational Cardiovascular and Renal Research Group at The Florey. His research aims to understand the pathophysiology of brain and kidney injury arising from sepsis, cardiac surgery, dialysis, seizures and heart failure. Armed with this knowledge, he hopes to develop novel diagnostics and therapeutics to improve patient-centred health outcomes. Professor Lankadeva is Founder-CEO of a Florey spinout company, PanAscea.

Professor Lankadeva has over 100 publications in high-impact medical journals including CirculationAnaesthesiaBritish Journal of AnaesthesiaAmerican Journal of Respiratory and Critical Care MedicineIntensive Care Medicine; Critical Care, Critical Care MedicineKidney International. The quality and clinical relevance of his work has been acknowledged by the award of more than $30 million of funding and he has delivered over 90 invited talks across Australia, England, Scotland, USA, Italy, China, Japan, Singapore, Malaysia, Sri Lanka, Thailand, Indonesia, and Canada. His discoveries have translated to 10 clinical trials across Australia, Europe, US and Asia.

He is an inventor on 6 patents and has received over 30 prestigious career awards from the Australian Institute of Policy and Science, Heart Foundation of Australia, Microcirculation Society, Hypertension Australia, Australian and New Zealand Microcirculation Society, World Congress for Microcirculation, Harold Mitchell Foundation, CASS Foundation and Jack Brockhoff Foundation. In addition, Professor Lankadeva currently holds appointments as Honorary Professorial positions at the Department of Critical Care, Melbourne Medical School, University of Melbourne and Department of Anaesthesia, Austin Hospital.

Career highlights

Current roles

  • Head of Stroke and Critical Care Priority Research Area
  • Head of Translational Cardiovascular and Renal Research Group
  • Founder-CEO of PanAscea Pty Ltd

Past roles

  • Head of Systems Neuroscience Theme
  • Co-Chair of Florey Staff Mentoring Committee

Other highlights

  • High international rankings in research fields [source – Expertscape], including Sepsis (Top 0.083%), Acute kidney injury (Top 0.11%), Cardiopulmonary bypass (Top 0.12%), Hypoxia (Top 0.057%)

Research project

Awards and achievements

  • 2025-2030 — Cardiovascular Health Medical Research Future Fund Grant (Chief Investigator A)
  • 2024-2029 — National Health and Medical Research Council Emerging Leader, Level 2, Investigator Grant (Chief Investigator A)
  • 2024-2029 — Early-to-Mid-Career Medical Research Future Fund Grant (Chief Investigator A)
  • 2024-2029 — Stem Cell Therapies Medical Research Future Fund Grant (Chief Investigator D)
  • 2023-2028 — Early-to-Mid Career Medical Research Future Fund Grant (Chief Investigator A)
  • 2023-2026 — Cardiovascular Health Mission Medical Research Future Fund Grant (Chief Investigator A)
  • 2022-2026 — Cardiovascular Health Mission Medical Research Future Fund Grant (Chief Investigator C)
  • 2022-2026 — National Heart Foundation Future Leader, Level 2, Fellowship (sole Chief Investigator A)
  • 2022-2024 — National Heart Foundation Vanguard Grant (Chief Investigator A)
  • 2021 — Paul Korner Innovation Award from the National Heart Foundation in recognition of the Top Ranked Future Leader, Level 2, Fellowship in Australia
  • 2021 — John Casley-Smith Award from the Australian and New Zealand Microcirculation Society in recognition for the Most Significant Scientific Contribution at the 21st Scientific Conference
  • 2021-2023 — National Heart Foundation, Vanguard Grant, (Chief Investigator A)
  • 2020 — Editor’s Recognition Award from the Journal of Microcirculation for the Top Cited Paper in 2020
  • 2020 — CASS Foundation Postdoctoral Travel Fellowship to deliver an invited faculty presentation at the Asia-Pacific Intensive Care Symposium in Singapore
  • 2020-2023 — National Health and Medical Research Council, Ideas Grant (Chief Investigator A)
  • 2020-2023 — National Health and Medical Research Council, Ideas Grant (Chief Investigator B)
  • 2017 — David Garlick EMCR Oral Presentation Award from Australia and New Zealand Microcirculation Society Conference
  • 2017 — Harold Mitchell Foundation Postdoctoral Travel Fellowship to deliver an invited presentation at the 11th World Congress for Microcirculation Conference in Vancouver, Canada
  • 2015 — Young Investigator Award of Excellence from the 10th World Congress for Microcirculation Conference, in recognition of an outstanding achievement by an Early Career Investigator in the field of Microcirculation, Kyoto, Japan
  • 2015 — Associate Professor Michael Perry Invited Speaker Award from the Australia and New Zealand Microcirculation Society (ANZMS) to represent ANZMS at the 10th World Congress for Microcirculation Conference, Kyoto, Japan
  • 2015 — Best Early Career Researcher Oral Presentation Award from the Australia and New Zealand Microcirculation Society Conference, New South Wales, Australia
  • 2014 — British Hypertension Society (BHS) Prize from Hypertension Australia Conference to represent this Australian society at the BHS Conference in Stratford-upon-Avon, United Kingdom
  • 2014 — Best Early Career Investigator Oral Presentation Award from Hypertension Australia, Adelaide, Australia

Research publications

Contact

Please enter your first name
Please enter your last name
Please enter a valid phone number
Please enter a correct email address
Please provide information regarding your enquiry